These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 17949450)
1. Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells. Ngan CY; Yamamoto H; Takagi A; Fujie Y; Takemasa I; Ikeda M; Takahashi-Yanaga F; Sasaguri T; Sekimoto M; Matsuura N; Monden M Cancer Sci; 2008 Jan; 99(1):129-39. PubMed ID: 17949450 [TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells. Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531 [TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel. Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991 [TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells. Liu HF; Hu HC; Chao JI Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607 [TBL] [Abstract][Full Text] [Related]
5. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666 [TBL] [Abstract][Full Text] [Related]
6. Survivin shRNA induces caspase-3-dependent apoptosis and enhances cisplatin sensitivity in squamous cell carcinoma of the tongue. Xu JH; Wang AX; Huang HZ; Wang JG; Pan CB; Zhang B Oncol Res; 2010; 18(8):377-85. PubMed ID: 20441052 [TBL] [Abstract][Full Text] [Related]
7. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines. Gu J; Yamamoto H; Lu X; Ngan CY; Tsujino T; Konishi K; Takemasa I; Ikeda M; Nagata H; Hashimoto S; Matsuzaki T; Sekimoto M; Takagi A; Monden M Digestion; 2006; 74(1):19-27. PubMed ID: 16988507 [TBL] [Abstract][Full Text] [Related]
8. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659 [TBL] [Abstract][Full Text] [Related]
9. Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells. Chen CA; Chen CC; Shen CC; Chang HH; Chen YJ J Med Food; 2013 Oct; 16(10):869-77. PubMed ID: 24074296 [TBL] [Abstract][Full Text] [Related]
10. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells. Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma. Lau CK; Yang ZF; Lam SP; Lam CT; Ngai P; Tam KH; Poon RT; Fan ST Cancer Biol Ther; 2007 Dec; 6(12):1900-7. PubMed ID: 18059167 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression. Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583 [TBL] [Abstract][Full Text] [Related]
13. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609 [TBL] [Abstract][Full Text] [Related]
14. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. Shen Z; Xu L; Li J; Zhang N Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1. Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674 [TBL] [Abstract][Full Text] [Related]
16. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers. Cheung CH; Chen HH; Kuo CC; Chang CY; Coumar MS; Hsieh HP; Chang JY Mol Cancer; 2009 Jul; 8():43. PubMed ID: 19575780 [TBL] [Abstract][Full Text] [Related]
17. Survivin activates NF‑κB p65 via the IKKβ promoter in esophageal squamous cell carcinoma. Zeng W; Li H; Chen Y; Lv H; Liu L; Ran J; Sun X; Bieerkehazhi S; Liu Y; Li X; Lai W; Watibieke J; Dawulietihan M; Li X; Li H Mol Med Rep; 2016 Feb; 13(2):1869-80. PubMed ID: 26718331 [TBL] [Abstract][Full Text] [Related]
18. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin. Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676 [TBL] [Abstract][Full Text] [Related]
19. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Feng Y; Ke C; Tang Q; Dong H; Zheng X; Lin W; Ke J; Huang J; Yeung SC; Zhang H Cell Death Dis; 2014 Feb; 5(2):e1088. PubMed ID: 24577086 [TBL] [Abstract][Full Text] [Related]
20. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation. Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]